SIFMA Compliance & Legal Society Annual Seminar

Summary

Goodwin Procter is sponsoring the SIFMA Compliance & Legal Society Annual Seminar. Jamie Fleckner, a partner in Goodwin Procter's Securities Litigation & White Collar Defense Group, will speak on the retirement and savings panel. The seminar will be held March 20-23, 2011 in Phoenix, AZ.

For more information, please visit: http://www.sifma.org/Events/2011/Compliance-and-Legal-Society-Annual-Seminar/Home/.

Speakers

James O. Fleckner
Partner
Chair, ERISA Litigation
jfleckner@goodwinlaw.com
Boston+1 617 570 1153
/en/people/f/fleckner-james

Related Content

Newsletters
January 27, 2025
Northern District of California Partially Dismisses Investor Suit Against Meta, but Claims Survive Challenging Statements About Consistent Application of Community Standards and Effect of Instagram on Youth
Newsletters
October 21, 2024
Delaware Chancery Court Grants Software Company’s Motion to Dismiss Stockholder Class Action Lawsuit After Stockholder Vote Cleansed Alleged Improprieties in Connection with Merger
Alert
July 11, 2024
U.S. Supreme Court Significantly Curtails SEC Enforcement Forum Discretion
Newsletters
June 1, 2024
Northern District of California Grants SEC Motion to Enforce Subpoena Compelling Testimony of Elon Musk
Newsletters
May 23, 2024
Courts Address Obligations (or Not) to Disclose Back and Forth with FDA. Read more about it and other key decisions in this edition.
Newsletters
May 1, 2024
Securities Snapshot: Court Confirms that Dilution of Shareholders May Constitute Both a Direct and Derivative Harm
Alert
April 17, 2024
SEC Speaks Conference 2024
Newsletters
March 25, 2024
Court Dismisses Class Action Against Biopharmaceutical Company for Failing to Disclose Progress of Competitor; Second Circuit Affirms Dismissal of Putative Class Action Against Allergan; Eleventh Circuit Affirms That “Toxic” Lender Qualified as a “Dealer” Under the Exchange Act Due to High-Volume Trading; Delaware Court of Chancery Invalidates Governance Rights in Stockholder Agreement

Awards and Rankings
November 7, 2024
Best Lawyers Best Law Firms 2025 Names Goodwin Biotechnology and Life Sciences Law Firm of the Year for the Eighth Time and Recognizes 55 Practice Areas
Awards and Rankings
October 9, 2024
Benchmark Litigation US 2025 Recognizes 45 Goodwin Litigators
Webinar
June 27, 2024
The Future of Non-Compete Agreements in America
Webinar
June 13, 2024 | 1:00 PM - 2:00 PM EDT
Antitrust Implications of State Regulators’ Increasing Scrutiny
Awards and Rankings
June 13, 2024
The Legal 500 US 2024 Recognizes 44 Goodwin Practices and 186 Lawyers
Awards and Rankings
June 6, 2024
Chambers USA 2024 Recognizes Goodwin Practices and Lawyers for Exceptional Client Service
Speaking Engagements
May 9, 2024
ACI's 19th FCPA & Anti-Corruption for the Life Sciences Industry
In the Press
May 3, 2024
The Big Lessons from the SEC Speaks Conference 2024 (Columbia Law School)

Summary

Speakers

James O. Fleckner

Related Content

Northern District of California Partially Dismisses Investor Suit Against Meta, but Claims Survive Challenging Statements About Consistent Application of Community Standards and Effect of Instagram on Youth

Delaware Chancery Court Grants Software Company’s Motion to Dismiss Stockholder Class Action Lawsuit After Stockholder Vote Cleansed Alleged Improprieties in Connection with Merger

U.S. Supreme Court Significantly Curtails SEC Enforcement Forum Discretion

Northern District of California Grants SEC Motion to Enforce Subpoena Compelling Testimony of Elon Musk

Courts Address Obligations (or Not) to Disclose Back and Forth with FDA. Read more about it and other key decisions in this edition.

Securities Snapshot: Court Confirms that Dilution of Shareholders May Constitute Both a Direct and Derivative Harm

SEC Speaks Conference 2024